Company Reaffirms Full Year Outlook for
2016
Consolidated Revenues of $1.84 billion, GAAP
Income from Continuing Operations of $34 million, GAAP Diluted EPS
from Continuing Operations of $0.23 and EBITDAR of $251
million(1) in the Second Quarter Include Net Costs of
$18 million Related to Impairments, Litigation, Transaction,
Integration, Research and Development, Debt Amendment, Other
Restructuring Costs, and Gain on Facility Swap
Core EBITDAR of $268 million(1)
and Core Diluted EPS from Continuing Operations of
$0.38(1) in the Second Quarter
Second Quarter GAAP Operating Cash Flows of
$135 million; Core Operating Cash Flows of $126
million(1)
Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND)
today announced its operating results for the second quarter ended
June 30, 2016.
Benjamin A. Breier, President and Chief Executive Officer of the
Company, commented, “We are pleased to report a solid second
quarter with results at the high end of our expectations. Notably,
our Kindred at Home (“KAH”) and Kindred Hospital Rehabilitation
Services (“KHRS”) businesses both achieved strong sequential and
year-over-year volume growth and operating performance. Our
Hospital Division increased same-facility admissions and
same-facility patient days and delivered stable second quarter
results in line with our expectations. We are pleased that the
Hospital Division’s performance has continued its significant
improvement from the operating trends experienced in the second
half of 2015. Solid execution remains our top priority across the
Company as we drive effective patient-centered care solutions and
adapt to a changing regulatory and operating environment. As
always, I thank Kindred’s 102,000 teammates for the exceptional
care, hope and dignity that they provide to more than one million
patients we see at Kindred each year.”
All financial and statistical information included in this press
release reflects the continuing operations of the Company’s
businesses for all periods presented unless otherwise
indicated.
Second Quarter Consolidated
Highlights(1):
- Consolidated revenues were $1.84
billion, a 0.5% year-over-year increase, while GAAP income from
continuing operations increased 2% to $34.4 million from $33.7
million in the same period in 2015. Core EBITDAR increased 2.3% to
$267.9 million compared to $261.8 million in the same period
in 2015. The increase in GAAP income from continuing operations and
core EBITDAR are both due primarily to revenue growth and operating
margin improvement in the KAH and KHRS businesses.
- GAAP operating cash flows increased to
$135.1 million compared to $100.4 million for the same period a
year ago. Core operating cash flows were $126.4 million compared to
core operating cash flows of $97.7 million for the same period a
year ago. Core free cash flows were $83.5 million compared to core
free cash flows of $63.1 million in the same period a year
ago.
____________
(1) See reconciliation of generally accepted accounting principles
(“GAAP”) results to non-GAAP results beginning on page 12. As used
herein, “EBITDAR” means earnings before interest, income taxes,
depreciation, amortization and rent.
Second Quarter Consolidated Highlights(1):
(Continued)
- GAAP diluted earnings per share (“EPS”)
from continuing operations was $0.23 and core diluted EPS from
continuing operations was $0.38 based upon 87.5 million weighted
average diluted shares. In the same period a year ago, the Company
reported GAAP diluted EPS of $0.25, while core diluted EPS was
$0.39 based upon 86.4 million weighted average diluted shares. GAAP
diluted EPS in the second quarter of 2016 includes $17.7 million
($13.2 million net of income taxes of $3.5 million and
noncontrolling interests of $1.0 million) or $0.15 per diluted
share of charges related to property and intangible asset
impairments, litigation, transaction, integration, research and
development, debt amendment, and other restructuring costs, and a
gain on facility swap. GAAP diluted EPS in the second quarter of
2015 includes $13.4 million ($12.1 million net of income
taxes of $1.3 million) or $0.14 per diluted share of charges
related to transaction, integration, litigation, and other
restructuring costs.
- The Kindred Board of Directors declared
a cash dividend of $0.12 per share on the Company’s common stock
payable on September 2, 2016 to shareholders of record as of the
close of business on August 18, 2016.
Second Quarter Segment
Highlights(1)(2):
KAH second quarter revenues increased 3% over the prior year
period to $624.2 million with home health episodic admissions
growing 3.5% and hospice average daily census growing 4% compared
to the same period last year. Segment EBITDAR (GAAP) for KAH
increased 8.6% to $107.0 million as compared to $98.6 million in
the prior year period and core EBITDAR increased 6.3% to $107.2
million compared to $100.8 million a year ago. These results were
achieved despite a 10% net reduction in home health branches and an
8.3% net reduction in hospice branches since the beginning of 2015,
primarily from branch consolidations. Average home health revenue
per branch grew 12.6% and average hospice revenue per branch grew
6.1% during the last twelve months compared to a year ago.
Kindred’s Hospital Division second quarter revenues increased
1.0% over the prior year period to $633.7 million, as a result of a
1% increase in revenues per patient day compared to the same period
last year. Same-hospital admissions were up 0.3% during the quarter
and same-hospital patient days were up 1.4%. Segment EBITDAR (GAAP)
in the Hospital Division for the second quarter decreased 3.3% to
$126.6 million from $131.0 million a year ago and core EBITDAR for
the second quarter decreased 4.3% to $125.9 million from
$131.5 million a year ago as operating expenses per patient day
increased 2% in the second quarter compared to a year ago.
Kindred Rehabilitation Services Division second quarter revenues
declined 6.0% to $365.9 million, while both segment EBITDAR (GAAP)
and core EBITDAR increased 7.6% to $63.7 million compared to $59.2
million in the same period last year. Strong performance in the
second quarter from KHRS freestanding inpatient rehabilitation
hospitals (“IRFs”) was offset by the impact of previously reported
contract losses in RehabCare that occurred primarily in the first
half of 2015. The KHRS segment achieved strong revenue growth of
11.3%, and both segment EBITDAR (GAAP) and core EBITDAR grew 13.3%
compared to the same period a year ago, with IRF same-hospital
discharges growing 4.1% during the quarter. RehabCare revenues
declined 17.2% to $196.1 million from a year ago, while segment
EBITDAR (GAAP), core EBITDAR and operating margins continued to
stabilize in the second quarter. RehabCare second quarter segment
and core EBITDAR increased to $13.3 million from
$12.0 million and operating margins increased to 6.8% from
5.9%, both compared to the first quarter of 2016.
Kindred’s Nursing Center Division second quarter revenues
declined 0.5% to $272.4 million compared to the same period last
year. Segment EBITDAR (GAAP) decreased 25.6% to $29.7 million and
core EBITDAR decreased 16.8% to $33.7 million, each the result
of a 1.2% decline in average daily census, start-up losses of $1
million at two newly opened transitional care centers, higher
contract labor costs, and for segment EBITDAR (GAAP), $4.0 million
of facility closure and restructuring costs.
____________
(1) See reconciliation of GAAP results to non-GAAP results
beginning on page 12. (2) See same-hospital and full segment data
on pages 8 through 11.
2016 Outlook
All forward-looking non-GAAP financial measures contained in
this section “2016 Outlook” are provided only on a non-GAAP basis.
This is due to the inherent difficulty of forecasting the timing or
amount of items that would be included in the most directly
comparable forward-looking GAAP financial measures. As a
result, reconciliation of the forward-looking non-GAAP financial
measures to GAAP financial measures is not available without
unreasonable effort and the Company is unable to address the
probable significance of the unavailable information.
The Company’s outlook does not reflect the potential impact of
the previously announced definitive agreement to sell 12 long-term
acute care (“LTAC”) hospitals to Curahealth, LLC (“Curahealth”).
The Company will make the appropriate adjustments following the
closing of the transaction.
The Company’s outlook also excludes transaction costs, the
effect of any reimbursement changes, debt refinancing costs,
severance, retirement, retention, restructuring costs, litigation
and related contingency expense, integration costs, business
interruption settlements, a gain on swap of facilities, research
and development, any further acquisitions or divestitures, any
impairment charges, any further issuances of common stock or any
repurchases of common stock.
Kindred today reaffirmed its outlook for 2016. Kindred
expects:
- Annual revenues of approximately $7.250
billion, with a range of $7.2 billion to $7.3 billion
- Core EBITDAR of approximately $990
million, with a range of $970 million to $1.010 billion
- Core diluted EPS from continuing
operations of approximately $0.90, with a range of $0.80 to
$1.00(1)
Following the Securities and Exchange Commission’s recently
updated Compliance and Disclosure Interpretations on the use of
non-GAAP financial measures, the Company has discontinued reporting
adjusted core diluted EPS from continuing operations.
For the third quarter of 2016, the Company expects core EBITDAR
to approximate $220 million to $235 million and core diluted EPS
from continuing operations to approximate $0.02 to $0.12.
Additionally, Kindred reaffirmed its preliminary outlook for
2017 core EBITDAR of at least $1 billion.
Mr. Breier commented, “We continue our efforts to grow our home
health, hospice and inpatient rehabilitation businesses through
organic growth, acquisitions and new joint venture arrangements and
we remain enthusiastic about the growth opportunities in these
businesses. We also remain focused on our preparations for LTAC
patient criteria and related mitigation initiatives, including the
ongoing optimization of our LTAC hospital portfolio. Our previously
announced transaction with Curahealth and our facility swap
transaction with Select Medical Holdings Corporation (NYSE:SEM)
reflect our commitment to this strategy. We believe our diversified
portfolio of assets, coordinated over an episode of care, with the
key enablers we have developed, continue to put Kindred in a unique
position to become the Post-Acute Benefits Management leader in the
many markets we now serve.”
Stephen D. Farber, Executive Vice President and Chief Financial
Officer of Kindred, added, “We are very pleased with our strong
second quarter cash flow performance that was in line with our
expectations, and coupled with our recent financing, enabled us to
end the quarter with excellent liquidity, with approximately $59
million drawn on our $900 million asset-based revolving credit
facility. We continue to expect to generate roughly
$300 million per year in core operating cash flows and
approximately half of that amount in core free cash flows.”
Cash Dividend
The Company announced that its Board of Directors has approved
the payment of a cash dividend of $0.12 per share of common stock
to be paid on September 2, 2016 to shareholders of record as of the
close of business on August 18, 2016.
____________
(1) The EPS estimate is based upon an estimated weighted average
annual diluted share count for 2016 of 88 million shares.
Conference Call
As previously announced, investors and the general public may
access a live webcast of the second quarter 2016 conference call
through a link on the Company’s website at
http://investors.kindredhealthcare.com. The conference call will be
held on August 5 at 10:00 a.m. (Eastern Time).
A telephone replay of the conference call will become available
at approximately 1:00 p.m. on August 5 by dialing
(719) 457-0820, access code: 3224094. The replay will be
available through August 14.
Forward-Looking Statements and Non-GAAP
Reconciliations
See page 12 for important disclosures regarding the Company’s
forward-looking statements and the non-GAAP financial
reconciliations that follow.
About Kindred Healthcare
Kindred Healthcare, Inc., a top-90 private employer in the
United States, is a FORTUNE 500 healthcare services company based
in Louisville, Kentucky with annual revenues of approximately $7.2
billion(1). At June 30, 2016, Kindred through its subsidiaries had
approximately 101,800 employees providing healthcare services in
2,684 locations in 46 states, including 97 transitional care
hospitals, 19 inpatient rehabilitation hospitals, 92 nursing
centers, 19 sub-acute units, 617 Kindred at Home home health,
hospice and non-medical home care sites of service, 105 inpatient
rehabilitation units (hospital-based) and contract rehabilitation
service businesses which served 1,735 non-affiliated sites of
service. Ranked as one of Fortune magazine’s Most Admired
Healthcare Companies for seven years, Kindred’s mission is to
promote healing, provide hope, preserve dignity and produce value
for each patient, resident, family member, customer, employee and
shareholder we serve. For more information, go to
www.kindredhealthcare.com. You can also follow us on Twitter and
Facebook.
____________
(1) Revenues based upon Kindred consolidated revenues for the
twelve months ended June 30, 2016.
KINDRED
HEALTHCARE, INC. Condensed Consolidated Statement of
Operations (Unaudited) (In thousands, except per share
amounts)
Three months
ended Six months ended June 30, June 30,
2016 2015 2016 2015 Revenues
$ 1,842,070 $ 1,833,475
$
3,680,041 $ 3,509,442 Salaries, wages
and benefits
928,954 935,687
1,855,168 1,782,780
Supplies
99,410 98,237
198,826 191,508 Rent
100,555 96,402
198,323 188,542 Other operating
expenses
217,850 212,117
432,551 409,844 General and
administrative expenses
338,672 334,805
694,199
740,907 Other income
(511 ) (569 )
(1,463
) (1,049 ) Litigation contingency expense
930 3,925
2,840 98,925 Impairment charges
6,131 -
13,919
6,726 Depreciation and amortization
40,257 38,625
80,938 77,560 Interest expense
58,056 57,170
115,555 119,688 Investment income
(497
) (1,030 )
(751 ) (1,771
)
1,789,807 1,775,369
3,590,105 3,613,660 Income (loss) from
continuing operations before income taxes
52,263 58,106
89,936 (104,218 ) Provision (benefit) for income taxes
17,882 24,396
29,718 (3,340 ) Income (loss) from continuing
operations
34,381 33,710
60,218 (100,878 )
Discontinued operations, net of income taxes: Income (loss) from
operations
3,016 (589 )
2,434 (4,013 ) Gain (loss) on
divestiture of operations
(83 ) 983
179 983 Income (loss)
from discontinued operations
2,933 394
2,613 (3,030 ) Net income (loss)
37,314 34,104
62,831 (103,908 ) (Earnings) loss
attributable to noncontrolling interests: Continuing operations
(13,522 ) (11,735 )
(26,036 ) (20,582 )
Discontinued operations
(3 ) 2
(5 ) 31
(13,525
) (11,733 )
(26,041 )
(20,551 ) Income (loss) attributable to Kindred
$
23,789 $ 22,371
$ 36,790
$ (124,459 ) Amounts attributable to Kindred stockholders:
Income (loss) from continuing operations
$ 20,859 $
21,975
$ 34,182 $ (121,460 ) Income (loss) from
discontinued operations
2,930 396
2,608 (2,999 ) Net income (loss)
$ 23,789 $ 22,371
$
36,790 $ (124,459 ) Earnings (loss) per common
share: Basic: Income (loss) from continuing operations
$
0.24 $ 0.25
$ 0.39 $ (1.47 ) Discontinued
operations: Income (loss) from operations
0.03 (0.01 )
0.03 (0.05 ) Gain (loss) on divestiture of operations
- 0.01
-
0.01 Income (loss) from discontinued operations
0.03 -
0.03
(0.04 ) Net income (loss)
$ 0.27 $ 0.25
$ 0.42 $ (1.51 ) Diluted: Income (loss)
from continuing operations
$ 0.23 $ 0.25
$
0.38 $ (1.47 ) Discontinued operations: Income (loss) from
operations
0.03 (0.01 )
0.03 (0.05 ) Gain (loss) on
divestiture of operations
- 0.01
- 0.01 Income (loss) from
discontinued operations
0.03 -
0.03 (0.04 ) Net income (loss)
$
0.26 $ 0.25
$ 0.41 $
(1.51 ) Shares used in computing earnings (loss) per common
share: Basic
86,836 86,045
86,713 82,828 Diluted
87,500 86,402
87,374 82,828 Cash dividends
declared and paid per common share
$ 0.12 $ 0.12
$ 0.24 $ 0.24
KINDRED HEALTHCARE,
INC. Condensed Consolidated Balance Sheet
(Unaudited) (In thousands, except per share amounts)
June 30, December 31, 2016
2015 ASSETS Current assets: Cash and cash equivalents
$ 100,056 $ 98,758 Insurance subsidiary investments
96,330 106,638 Accounts receivable less allowance for loss
1,264,540 1,194,868 Inventories
28,178 27,791 Income
taxes
11,223 11,790 Other
70,384
61,054
1,570,711 1,500,899 Property and
equipment
2,165,547 2,162,398 Accumulated depreciation
(1,226,072 ) (1,190,402 )
939,475 971,996 Goodwill
2,690,202 2,669,810
Intangible assets less accumulated amortization
781,203
755,655 Assets held for sale
4,459 613 Insurance subsidiary
investments
199,075 204,498 Deferred tax assets
81,324 104,130 Acquisition deposit
- 18,489 Other
281,073 242,169 (a) Total assets
$ 6,547,522 $ 6,468,259
LIABILITIES
AND EQUITY Current liabilities: Accounts payable
$
196,952 $ 187,061 Salaries, wages and other compensation
419,251 404,925 Due to third party payors
33,136
36,251 Professional liability risks
60,367 64,099 Other
accrued liabilities
271,972 394,246 Long-term debt due
within one year
27,793 24,630
1,009,471 1,111,212 Long-term debt
3,218,679
3,086,348 (a) Professional liability risks
277,844 263,273
Deferred credits and other liabilities
312,001 301,379
Equity: Stockholders' equity: Common stock, $0.25 par value;
authorized 175,000 shares; issued 85,266 shares - June 30, 2016 and
83,792 shares - December 31, 2015
21,317 20,948 Capital in
excess of par value
1,724,018 1,737,747 Accumulated other
comprehensive loss
(4,892 ) (2,632 ) Accumulated
deficit
(219,514 ) (256,209 )
1,520,929 1,499,854 Noncontrolling interests
208,598 206,193 Total equity
1,729,527 1,706,047 Total liabilities
and equity
$ 6,547,522 $ 6,468,259
__________
(a)
The balance sheet at December 31, 2015
includes a correction made during the second quarter ended June 30,
2016 to present capitalized lender fees of $47.0 million as an
offset to long-term debt rather than the previous reporting of
these amounts as other long-term assets. This presentation is in
accordance with GAAP and is consistent with the presentation at
June 30, 2016.
KINDRED HEALTHCARE, INC. Condensed
Consolidated Statement of Cash Flows (Unaudited) (In
thousands)
Three months ended Six months ended June 30,
June 30, 2016 2015 2016 2015
Cash flows from operating activities: Net income (loss)
$
37,314 $ 34,104
$ 62,831 $ (103,908 )
Adjustments to reconcile net income (loss)
to net cash provided by (used in) operating activities:
Depreciation expense
34,435 31,313
68,392 63,458
Amortization of intangible assets
5,957 7,536
12,783
14,468 Amortization of stock-based compensation costs
5,639
6,746
10,043 12,570 Amortization of deferred financing costs
3,708 3,539
7,275 6,601 Payment of capitalized lender
fees related to debt issuance
(7,333 ) -
(7,333 ) (28,012 ) Provision for doubtful accounts
9,221 10,511
20,946 18,803 Deferred income taxes
17,802 21,130
29,298 (4,450 ) Impairment charges
6,131 -
13,919 6,726 (Gain) loss on divestiture of
discontinued operations
83 (983 )
(179 ) (983
) Other
656 4,975
959 6,972 Change in operating
assets and liabilities: Accounts receivable
(13,229 )
(7,733 )
(101,121 ) (39,389 ) Inventories and other
assets
(10,161 ) (17,608 )
(15,393 )
35,414 Accounts payable
23,077 (12,900 )
12,456
(12,435 ) Income taxes
707 1,923
780 (3,845 ) Due to
third party payors
351 (3,554 )
(4,492 )
(18,973 ) Other accrued liabilities
20,670
21,380
(109,198 ) 7,760
Net cash provided by (used in) operating activities
135,028 100,379
1,966
(39,223 ) Cash flows from investing
activities: Routine capital expenditures
(28,724 )
(24,500 )
(46,830 ) (45,269 ) Development capital
expenditures
(8,707 ) (518 )
(18,726 )
(6,306 ) Acquisitions, net of cash acquired
(1,372 )
(2,684 )
(27,711 ) (661,755 ) Acquisition deposits
- -
18,489 195,000 Sale of assets
142 2,229
1,223 3,177 Proceeds from senior unsecured notes offering
held in escrow
- -
- 1,350,000 Interest in escrow for
senior unsecured notes
- -
- 23,438 Purchase of
insurance subsidiary investments
(20,154 ) (16,911 )
(52,995 ) (42,829 ) Sale of insurance subsidiary
investments
15,713 12,764
46,603 34,793 Net change in
insurance subsidiary cash and cash equivalents
13,201 (5,205
)
23,159 (5,763 ) Net change in other investments
583
175
(33,398 ) 199 Other
792
(798 )
(1,127 ) (793 ) Net cash
provided by (used in) investing activities
(28,526
) (35,448 )
(91,313 )
843,892 Cash flows from financing activities:
Proceeds from borrowings under revolving credit
244,300
347,700
778,000 1,155,150 Repayment of borrowings under
revolving credit
(524,600 ) (360,100 )
(827,700 ) (970,150 ) Proceeds from issuance of term
loan, net of discount
198,100 -
198,100 199,000
Proceeds from other long-term debt
- -
750 -
Repayment of Gentiva debt
- -
- (1,177,363 )
Repayment of term loan
(3,508 ) (6,005 )
(6,511 ) (6,005 ) Repayment of other long-term debt
(270 ) (459 )
(550 ) (900 ) Payment of
deferred financing costs
(141 ) (445 )
(292
) (2,983 ) Issuance of common stock in connection with
employee benefit plans
- 139
- 205
Payment of costs associated with issuance
of common stock and tangible equity units
- -
- (915 ) Payment of dividend for mandatory
redeemable preferred stock
(2,853 ) (2,654 )
(5,654 ) (5,432 ) Dividends paid
(10,225
) (10,027 )
(20,293 ) (20,002 ) Contributions
made by noncontrolling interests
1,900 -
6,268 -
Distributions to noncontrolling interests
(14,231 )
(10,119 )
(30,546 ) (21,138 ) Purchase of
noncontrolling interests
- -
(1,000 ) - Other
- 50
73
1,212 Net cash provided by (used in) financing
activities
(111,528 ) (41,920 )
90,645 (849,321 ) Change in cash and cash
equivalents
(5,026 ) 23,011
1,298 (44,652 )
Cash and cash equivalents at beginning of period
105,082 96,525
98,758
164,188 Cash and cash equivalents at end of
period
$ 100,056 $ 119,536
$
100,056 $ 119,536
KINDRED
HEALTHCARE, INC. Condensed Consolidated and Business Segment
Data (Unaudited) (In thousands, except per share
amounts)
Second quarter 2015 Quarters 2016 Quarters
% change v. First Second Third
Fourth First Second prior year
Condensed consolidated income statement data: GAAP
presentation: Revenues $ 1,675,967 $ 1,833,475 $ 1,764,516 $
1,780,949 $ 1,837,971 $ 1,842,070 0.5 Operating expenses 1,645,439
1,584,202 1,567,381 1,583,096 1,604,604 1,591,436 0.5 Rent 92,140
96,402 96,244 97,823 97,768 100,555 4.3 Depreciation and
amortization 38,935 38,625 39,329 40,362 40,681 40,257 4.2
Interest, net 61,777 56,140
56,008 55,664 57,245
57,559 2.5
Income (loss) from continuing operations
before income taxes
(162,324 ) 58,106 5,554 4,004 37,673 52,263 (10.1 ) Provision
(benefit) for income taxes (27,736 ) 24,396
12,523 (51,980 ) 11,836
17,882 (26.7 ) Income (loss) from continuing operations
(134,588 ) 33,710 (6,969 ) 55,984 25,837 34,381 2.0 Noncontrolling
interests (8,847 ) (11,735 ) (9,900 )
(12,082 ) (12,514 ) (13,522 ) 15.2 Net income (loss)
attributable to Kindred $ (143,435 ) $ 21,975 $ (16,869 ) $
43,902 $ 13,323 $ 20,859 (5.1 ) Diluted
EPS $ (1.80 ) $ 0.25 $ (0.20 ) $ 0.50 $ 0.15 $ 0.23 (8.0 ) Diluted
shares 79,575 86,402 86,184 87,232 87,249 87,500 1.3
Core
presentation (a): EBITDAR $ 234,211 $ 261,800 $ 236,477 $
247,839 $ 246,834 $ 267,895 2.3 Rent 91,199 95,528 95,436 96,934
97,517 100,093 4.8 Interest, net 44,346 56,140 56,008 55,664 57,245
57,559 2.5 Provision for income taxes 22,466 25,721 15,298 13,758
16,546 21,417 (16.7 ) Net income attributable to Kindred 28,418
34,051 20,506 29,039 22,331 34,031 (0.1 ) Core diluted EPS $
0.34 $ 0.39 $ 0.23 $ 0.33 $ 0.25 $ 0.38 (2.6 ) Diluted shares
82,422 86,402 86,892 87,232 87,249 87,500 1.3
Revenues by
segment: Hospital division $ 640,483 $ 627,206 $ 579,497 $
593,593 $ 643,299 $ 633,695 1.0 Kindred at Home: Home health
300,867 427,820 424,054 425,759 430,035 438,556 2.5 Hospice
119,057 178,005 181,140
178,325 176,426 185,641 4.3
419,924 605,825 605,194 604,084 606,461 624,197 3.0 Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
151,564 152,544 149,435 155,579 165,774 169,815 11.3 RehabCare
252,595 236,791 219,518
206,582 204,248 196,075
(17.2 ) 404,159 389,335 368,953 362,161 370,022 365,890 (6.0 )
Nursing center division 274,308 273,870
270,510 273,387 272,227
272,395 (0.5 ) 1,738,874 1,896,236 1,824,154
1,833,225 1,892,009 1,896,177 - Eliminations (62,907 )
(62,761 ) (59,638 ) (52,276 ) (54,038 )
(54,107 ) (13.8 ) $ 1,675,967 $ 1,833,475 $
1,764,516 $ 1,780,949 $ 1,837,971 $ 1,842,070
0.5 (a) See reconciliation of GAAP results to
non-GAAP results beginning on page 12.
KINDRED
HEALTHCARE, INC. Condensed Consolidated and Business Segment
Data (Continued) (Unaudited) (In thousands, except
statistics)
Second quarter 2015 Quarters
2016 Quarters % change v. First Second
Third Fourth First Second prior
year Segment EBITDAR (GAAP): Hospital division $ 134,111
$ 130,967 $ 95,983 $ 116,454 $ 134,571 $ 126,589 (3.3 ) Kindred at
Home: Home health 45,696 72,329 65,584 67,032 66,941 75,790 4.8
Hospice 16,479 26,238 33,707
28,668 24,525 31,225
19.0 62,175 98,567 99,291 95,700 91,466 107,015 8.6 Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
44,564 44,531 42,141 44,891 47,870 50,469 13.3 RehabCare
15,708 14,681 14,544
(1,118 ) 11,987 13,269 (9.6 ) 60,272
59,212 56,685 43,773 59,857 63,738 7.6 Nursing center division
36,963 39,877 35,923 36,601 30,100 29,652 (25.6 )
Core EBITDAR by segment (a): Hospital division $ 134,786 $
131,532 $ 97,128 $ 117,675 $ 135,495 $ 125,932 (4.3 ) Kindred at
Home: Home health 46,798 72,917 68,155 68,826 65,803 75,859 4.0
Hospice 16,996 27,887 34,025
30,212 24,866 31,329
12.3 63,794 100,804 102,180 99,038 90,669 107,188 6.3
Kindred Rehabilitation Services: Kindred Hospital Rehabilitation
Services 44,564 44,531 42,141 45,098 47,870 50,469 13.3 RehabCare
16,493 14,681 14,544
11,858 11,987 13,269 (9.6
) 61,057 59,212 56,685 56,956 59,857 63,738 7.6 Nursing center
division 36,963 40,461 35,923 36,601 30,100 33,662 (16.8 ) Support
center (62,389 ) (70,209 ) (55,439 )
(62,431 ) (69,287 ) (62,625 ) 10.8 $ 234,211 $
261,800 $ 236,477 $ 247,839 $ 246,834 $
267,895 2.3
EBITDAR margin by segment:
Hospital division 20.9 20.9 16.6 19.6 20.9 20.0 (0.9 ) Kindred at
Home: Home health 15.2 16.9 15.5 15.7 15.6 17.3 0.4 Hospice 13.8
14.7 18.6 16.1 13.9 16.8 2.1 Kindred at Home 14.8 16.3 16.4 15.8
15.1 17.1 0.8 Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services 29.4 29.2 28.2 28.9 28.9 29.7 0.5 RehabCare
6.2 6.2 6.6 (0.5 ) 5.9 6.8 0.6 Kindred Rehabilitation Services 14.9
15.2 15.4 12.1 16.2 17.4 2.2 Nursing center division 13.5 14.6 13.3
13.4 11.1 10.9 (3.7 )
Core EBITDAR margin by segment:
Hospital division 21.0 21.0 16.8 19.8 21.1 19.9 (1.1 ) Kindred at
Home: Home health 15.6 17.0 16.1 16.2 15.3 17.3 0.3 Hospice 14.3
15.7 18.8 16.9 14.1 16.9 1.2 Kindred at Home 15.2 16.6 16.9 16.4
15.0 17.2 0.6 Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services 29.4 29.2 28.2 29.0 28.9 29.7 0.5 RehabCare
6.5 6.2 6.6 5.7 5.9 6.8 0.6 Kindred Rehabilitation Services 15.1
15.2 15.4 15.7 16.2 17.4 2.2 Nursing center division 13.5 14.8 13.3
13.4 11.1 12.4 (2.4 ) Consolidated 14.0 14.3 13.4 13.9 13.4 14.5
0.2 (a) See reconciliation of GAAP results to
non-GAAP results beginning on page 12.
KINDRED
HEALTHCARE, INC. Condensed Business Segment Data
(Continued) (Unaudited)
Second quarter 2015
Quarters 2016 Quarters % change v. First
Second Third Fourth First Second
prior year Hospital division: End of period data:
Number of transitional care hospitals 97 96 95 95 95 97 Number of
licensed beds 7,147 7,124 7,094 7,094 7,089 7,067 Revenue mix %:
Medicare 56.8 55.2 57.1 57.3 57.8 55.5 Medicaid 5.5 5.3 5.3 5.1 4.2
4.2 Medicare Advantage 11.9 11.6 10.8 11.1 11.5 12.0 Medicaid
Managed 4.7 5.6 6.1 6.2 5.6 6.3 Commercial insurance and other 21.1
22.3 20.7 20.3 20.9 22.0 Admissions: Medicare 8,775 8,267 7,976
8,169 8,919 8,253 (0.2 ) Medicaid 610 610 556 520 463 386 (36.7 )
Medicare Advantage 1,555 1,352 1,212 1,304 1,453 1,382 2.2 Medicaid
Managed 643 675 646 612 733 768 13.8 Commercial insurance and other
1,868 1,815 1,763 1,701 1,871
1,807 (0.4 ) 13,451 12,719 12,153
12,306 13,439 12,596 (1.0 ) Patient days:
Medicare 228,483 218,577 210,870 210,409 229,004 219,013 0.2
Medicaid 28,663 25,213 23,167 21,795 21,134 19,409 (23.0 ) Medicare
Advantage 48,448 44,740 39,585 41,079 45,760 47,697 6.6 Medicaid
Managed 22,013 24,833 24,412 24,802 25,341 27,267 9.8 Commercial
insurance and other 62,241 62,922 58,631
57,321 62,769 63,009 0.1 389,848
376,285 356,665 355,406 384,008 376,395
- Average length of stay: Medicare 26.0 26.4 26.4 25.8 25.7 26.5
0.4 Medicaid 47.0 41.3 41.7 41.9 45.6 50.3 21.8 Medicare Advantage
31.2 33.1 32.7 31.5 31.5 34.5 4.2 Medicaid Managed 34.2 36.8 37.8
40.5 34.6 35.5 (3.5 ) Commercial insurance and other 33.3 34.7 33.3
33.7 33.5 34.9 0.6 Weighted average 29.0 29.6 29.3 28.9 28.6 29.9
1.0 Revenues per admission: Medicare $ 41,483 $ 41,892 $ 41,451 $
41,656 $ 41,717 $ 42,579 1.6 Medicaid 57,594 54,795 55,415 57,724
57,928 69,797 27.4 Medicare Advantage 48,908 53,578 51,495 50,680
51,080 55,105 2.9 Medicaid Managed 46,740 51,950 54,976 60,263
49,287 51,696 (0.5 ) Commercial insurance and other 72,395 77,110
68,151 70,735 71,651 77,193 0.1 Weighted average 47,616 49,312
47,683 48,236 47,868 50,309 2.0 Revenues per patient day: Medicare
$ 1,593 $ 1,584 $ 1,568 $ 1,617 $ 1,625 $ 1,605 1.3 Medicaid 1,226
1,326 1,330 1,377 1,269 1,388 4.7 Medicare Advantage 1,570 1,619
1,577 1,609 1,622 1,597 (1.4 ) Medicaid Managed 1,365 1,412 1,455
1,487 1,426 1,456 3.1 Commercial insurance and other 2,173 2,224
2,049 2,099 2,136 2,214 (0.4 ) Weighted average 1,643 1,667 1,625
1,670 1,675 1,684 1.0
Medicare case mix index (discharged
patients only)
1.166 1.163 1.150 1.164 1.163 1.179 1.4 Average daily census 4,332
4,135 3,877 3,863 4,220 4,136 - Occupancy % 69.2 66.1 62.2 62.2
68.0 67.5 2.1 Same-hospital data: Revenues ($ 000s) (a) $ 634,975 $
605,410 $ 562,658 $ 579,396 $ 643,413 $ 619,427 2.3 Admissions:
Medicare 8,652 8,031 7,769 8,039 8,919 8,083 0.6 Medicaid 602 557
519 466 463 371 (33.4 ) Medicare Advantage 1,546 1,299 1,179 1,255
1,453 1,339 3.1 Medicaid Managed 640 640 619 590 733 761 18.9
Commercial insurance and other 1,840 1,746
1,713 1,653 1,871 1,751 0.3 13,280
12,273 11,799 12,003 13,439
12,305 0.3 Patient days: Medicare 225,992 212,221 205,802 207,010
229,004 214,629 1.1 Medicaid 28,458 22,999 21,502 20,001 21,134
18,340 (20.3 ) Medicare Advantage 48,276 42,863 37,863 39,656
45,760 46,522 8.5 Medicaid Managed 21,933 23,722 23,329 24,136
25,341 26,795 13.0 Commercial insurance and other 61,715
60,559 57,199 55,701 62,769
60,984 0.7 386,374 362,364 345,695
346,504 384,008 367,270 1.4 Total average length of
stay 29.1 29.5 29.3 28.9 28.6 29.8 1.0 Total revenues per patient
day $ 1,643 $ 1,671 $ 1,628 $ 1,672 $ 1,676 $ 1,687 1.0
_____________
(a) See reconciliation of same-hospital revenues to reported
revenues for the Hospital Division on page 15.
KINDRED HEALTHCARE, INC. Condensed Business Segment Data
(Continued) (Unaudited)
Second quarter
2015 Quarters 2016 Quarters % change v.
First Second Third Fourth First
Second prior year
Kindred at Home (data combined to
include Kindred and Gentiva for each historical period):
Home Health: Sites of service (at end of period) 415 411 388 373
384 384 Revenue mix %: Medicare 80.9 80.4 80.0 80.0 79.8 79.3
Medicaid 2.1 2.1 2.1 2.1 2.1 2.1 Commercial and other 7.3 7.9 8.2
8.5 8.4 8.2 Commercial paid at episodic rates 9.7 9.6 9.7 9.4 9.7
10.4 Episodic revenues ($ 000s) $ 308,317 $ 324,027 $ 319,820 $
320,698 $ 325,821 $ 332,193 2.5 Total episodic admissions 69,936
67,808 66,753 66,157 71,426 70,212 3.5 Medicare episodic admissions
61,186 59,394 58,479 57,804 62,011 60,730 2.2 Total episodes
110,980 109,599 108,519 108,300 113,887 113,278 3.4 Episodes per
admission 1.59 1.62 1.63 1.64 1.59 1.61 (0.6 ) Revenue per episode
$ 2,778 $ 2,956 $ 2,947 $ 2,961 $ 2,861 $ 2,933 (0.8 ) Hospice:
Sites of service (at end of period) 190 185 181 175 177 177
Admissions 13,164 12,574 12,091 12,129 13,234 13,149 4.6 Average
length of stay 95 93 101 100 92 91 (2.2 ) Patient days 1,150,841
1,190,604 1,211,291 1,185,330 1,183,908 1,238,584 4.0 Revenue per
patient day $ 151 $ 150 $ 150 $ 150 $ 149 $ 150 - Average daily
census 12,787 13,084 13,166 12,884 13,010 13,611 4.0
Community Care and other revenues
(included in Home Health business segment) ($ 000s)
$ 65,530 $ 67,647 $ 67,338 $ 67,684 $ 66,305 $ 68,229 0.9
Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services: Freestanding IRFs: End of period data:
Number of IRFs 16 16 18 18 19 19 Number of licensed beds 829 829
919 919 969 969 Discharges (a) 3,806 3,927 3,941 4,317 4,448 4,646
18.3 Same-hospital discharges (a) 3,806 3,927 3,842 4,040 4,016
4,089 4.1 Occupancy % (a) 73.2 71.5 68.7 68.0 70.6 70.6 (1.3 )
Average length of stay (a) 13.7 13.1 13.2 12.7 13.2 12.9 (1.5 )
Revenue per discharge (a) $ 19,517 $ 19,325 $ 18,992 $ 18,640 $
19,731 $ 19,318 - Contract services: Sites of service (at end of
period): Inpatient rehabilitation units 100 99 101 100 104 105 LTAC
hospitals 120 120 119 119 119 121 Sub-acute units 8 8 7 7 7 7
Outpatient units 138 139 135 130
139 138 366 366 362 356
369 371 Revenue per site $ 211,151 $ 209,436 $
206,041 $ 210,978 $ 211,417 $ 215,798 3.0 RehabCare: Sites
of service (at end of period) 1,829 1,789 1,821 1,798 1,767 1,759
Revenue per site $ 138,106 $ 132,359 $ 120,548 $ 114,896 $ 115,590
$ 111,470 (15.8 )
Nursing center division: End of
period data: Number of nursing centers 90 90 90 90 92 92 Number of
licensed beds 11,535 11,535 11,535 11,535 11,815 11,815 Admissions
(b) 10,376 9,831 9,558 9,237 9,815 9,480 (3.6 ) Medicare average
length of stay (b) 28.9 28.9 28.5 28.4 28.2 28.4 (1.7 ) Patient
days (b) 861,278 852,691 851,332 845,924 846,578 842,681 (1.2 )
Revenues per patient day (b) $ 319 $ 321 $ 318 $ 323 $ 322 $ 323
0.6 Average daily census (b) 9,570 9,370 9,254 9,195 9,303 9,260
(1.2 ) Occupancy % (b) 81.3 79.6 78.6 78.1 77.3 76.7 (3.6 )
(a) Excludes non-consolidating IRF. (b) Excludes managed
facilities.
Forward-Looking Statements
This earnings release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of
1934, as amended. These forward-looking statements include, but are
not limited to, all statements regarding the Company’s expected
future financial position, results of operations, cash flows,
dividends, financing plans, business strategy, budgets, capital
expenditures, competitive positions, growth opportunities, plans
and objectives of management, government investigations, regulatory
matters, and statements containing the words such as “anticipate,”
“approximate,” “believe,” “plan,” “estimate,” “expect,” “project,”
“could,” “would,” “should,” “will,” “intend,” “may,” “potential,”
“upside,” and other similar expressions. Statements in this
earnings release concerning the Company’s business outlook or
future economic performance, anticipated profitability, revenues,
expenses, dividends or other financial items, product or services
line growth, and expected outcome of government investigations and
other regulatory matters, together with other statements that are
not historical facts, are forward-looking statements that are
estimates reflecting the best judgment of the Company based upon
currently available information.
Such forward-looking statements are inherently uncertain, and
stockholders and other potential investors must recognize that
actual results may differ materially from the Company’s
expectations as a result of a variety of factors. Such
forward-looking statements are based upon management’s current
expectations and include known and unknown risks, uncertainties and
other factors, many of which the Company is unable to predict or
control, that may cause the Company’s actual results, performance
or plans to differ materially from any future results, performance
or plans expressed or implied by such forward-looking statements.
These statements involve risks, uncertainties and other factors
detailed from time to time in the Company’s Annual Report on Form
10-K, Quarterly Reports on Form 10-Q and Current Reports on Form
8-K filed with the Securities and Exchange Commission.
Many of these factors are beyond the Company’s control. The
Company cautions investors that any forward-looking statements made
by the Company are not guarantees of future performance. The
Company disclaims any obligation to update any such factors or to
announce publicly the results of any revisions to any of the
forward-looking statements to reflect future events or
developments.
Non-GAAP Measurements
In addition to the results provided in accordance with GAAP, the
Company has provided information in this earnings release to
compute certain non-GAAP measures. The use of these non-GAAP
measures are not intended to replace the presentation of the
Company’s financial results in accordance with GAAP.
Reconciliations of these non-GAAP measures to the most directly
comparable GAAP measures are included in the following pages of
this earnings release.
EBITDAR: The Company defines EBITDAR as earnings before
interest, income taxes, depreciation, amortization and rent, and
believes that the presentation of EBITDAR is useful to the
investors because creditors, securities analysts and investors use
EBITDAR as a measure of earnings used to compare the performance of
companies in the healthcare industry before consideration of the
capital structure of fixed assets and financing costs, which can
vary significantly among companies.
For each of the Company’s segments, EBITDAR is a measure of
performance used by the Company’s chief operating decision makers
in accordance with “Accounting Standard Codification 280—Segment
Reporting.” In this context, the Company defines segment EBITDAR as
earnings before interest, income taxes, depreciation, amortization
and rent, excluding litigation contingency expense, impairment
charges, transaction costs and the allocation of support center
overhead.
Core Operating Results: The Company calculates core operating
results, including core net income attributable to Kindred, core
EBITDAR and core diluted EPS, by excluding charges related to
transaction, integration, severance, retirement, retention,
impairments, business interruption settlements, research and
development, restructuring, debt amendment costs, gain on facility
swap and litigation. The Company believes that the presentation of
core operating results provides additional information to investors
to facilitate the comparison between periods by excluding certain
charges that are not representative of its ongoing operations due
to the materiality and nature of the charges. The Company’s
management uses core net income attributable to Kindred, core
EBITDAR and core diluted EPS as meaningful measures of operational
performance, and for the attainment of internal incentive
compensation goals, in addition to other measures. The Company uses
these measures to assess the relative performance and attainment of
internal incentive compensation goals of its operating divisions,
as well as the employees that operate these businesses. In
addition, the Company believes these measures are important,
because securities analysts and investors use these measures to
compare the Company’s performance to other companies in the
healthcare industry.
Non-GAAP Measurements (Continued)
Same-Hospital Revenues: The same-hospital revenues are
calculated by excluding from the Company's Hospital Division
revenues the results from five hospitals acquired in 2016, three
hospitals sold in 2016 and two hospitals that closed during 2015.
The Company believes the presentation of same-hospital revenues
provides investors, equity analysts and others with useful
information regarding the performance of the Company's hospital
operations that are comparable for the periods presented.
For EBITDAR, core net income attributable to Kindred, and core
EBITDAR, the Company believes that income (loss) from continuing
operations is the most comparable GAAP measure. For core diluted
EPS, the Company believes that GAAP diluted earnings (loss) per
share from continuing operations is the most comparable GAAP
measure. Readers of the Company’s financial information should
consider income (loss) from continuing operations and diluted
earnings (loss) per share from continuing operations as important
measures of the Company’s financial performance, because they
provide the most complete measures of its performance. For
same-hospital revenues, the Company believes that reported hospital
segment revenues is the most comparable GAAP measure. Readers of
the Company’s financial information should consider reported
hospital segment revenues as an important measure of the Company’s
Hospital Division financial performance because it provides the
most complete measure of its performance. Operating results
presented on a core basis, as well as a same-hospital basis, should
be considered in addition to, not as a substitute for, or superior
to, financial measures based upon GAAP as an indicator of operating
performance.
Also in this earnings release, the Company provides the
financial measures of operating cash flows and free cash flows
excluding certain items, which the Company refers to as core
operating cash flows and core free cash flows, respectively.
Core Operating Cash Flows: The Company defines core operating
cash flows as operating cash flows excluding payments related to
transaction, severance, retirement, retention, business
interruption settlements, restructuring, debt refinancing costs,
and fees and litigation, net of income tax benefits. The Company
believes that core operating cash flows provide important
information to investors for comparability to other companies that
use similar measures. Management uses core operating cash flows to
evaluate consolidated operating performance and in making decisions
related to acquisitions, development capital expenditures,
dividends, long-term debt repayments and other uses.
Core Free Cash Flows: The Company defines core free cash flows
as operating cash flows excluding payments related to transaction,
severance, retirement, retention, business interruption
settlements, restructuring, debt refinancing costs, and fees and
litigation, net of income tax benefits but including routine
capital expenditures and distributions to noncontrolling interests.
The Company believes that core free cash flows provide important
information to investors for comparability to other companies that
use similar measures. Management uses core free cash flows in
making decisions related to acquisitions, development capital
expenditures, dividends, long-term debt repayments and other
uses.
The Company recognizes that core operating cash flows and core
free cash flows are non-GAAP measures and are not intended to
replace the presentation of the Company’s cash flows in accordance
with GAAP. For core operating cash flows and core free cash flows,
the Company believes net cash flows provided by operating
activities is the most comparable GAAP measure. Readers of the
Company’s financial information should consider net cash flows
provided by operating activities as an important measure because it
provides the most complete measure of cash provided by operating
activities. Core operating cash flows and core free cash flows
should be considered in addition to, not as a substitute for, or
superior to, financial measures based upon GAAP as an indicator of
the Company’s cash flows provided by operating activities.
KINDRED HEALTHCARE, INC. Reconciliation of GAAP
Results to Non-GAAP Measurements (Unaudited) (In
thousands, except per share amounts and statistics)
In addition to the results provided in
accordance with GAAP, the Company has provided information in this
earnings release to compute certain non-GAAP measurements for the
three months and six months ended June 30, 2016 and 2015 before
certain charges or on a core basis. The charges that were excluded
from core operating results are denoted in the tables below.
The income tax benefit associated with the excluded charges was
calculated using an effective income tax rate of 19.9% and 9.9% for
the three months ended June 30, 2016 and 2015, respectively, and
26.2% and 21.9% for the six months ended June 30, 2016 and 2015,
respectively. The difference in the effective income tax rate for
both periods compared to the same prior year periods is
attributable to the composition of charges that are non-deductible
for income tax purposes, including the impairment charges and
litigation contingency expense.
Three months ended
Six months ended June 30, June 30, 2016
2015 2016 2015 Reconciliation of income from
continuing operations before charges: As reported: Income
(loss) from continuing operations attributable to Kindred $ 20,859
$ 21,975 $ 34,182 ($121,460 ) Diluted earnings (loss) per common
share from continuing operations $ 0.23 $ 0.25 $ 0.38 ($1.47 )
Weighted average diluted shares outstanding 87,500 86,402 87,374
82,828 Detail of charges: Litigation contingency expense
($930 ) ($3,925 ) ($2,840 ) ($98,925 ) Retirement and severance
costs (2,016 ) - (3,598 ) (4,961 ) Facility/branch
closings/consolidations (2,784 ) (3,386 ) (3,125 ) (5,680 )
Impairment charges (6,131 ) - (13,919 ) - Business interruption
settlements 171 - 1,309 - Research and development (3,076 ) -
(3,939 ) - Gain on facility swap 1,103 - 1,103 - Debt amendment
fees not capitalized (1,103 ) - (1,103 ) - Gentiva transaction and
integration costs: Professional and consulting fees (1,319 ) (1,931
) (2,367 ) (34,065 ) Severance and retention (355 ) (2,411 ) (910 )
(56,875 ) Lease termination (charged to rent expense) - (203 ) -
(792 ) Pre-closing financing charges (charged to general and
administrative expenses) - - - (6,005 ) Pre-closing financing
charges (charged to interest expense) - - - (17,431 ) Trade name
impairment charges - - - (6,726 ) Lease termination (charged to
rent expense) (462 ) (671 ) (713 ) (1,023 ) Other transaction costs
(821 ) (874 ) (1,339 ) (2,973 ) (17,723
) (13,401 ) (31,441 ) (235,456 ) Income tax benefit 3,535
1,325 8,245 51,527
Charges net of income taxes (14,188 ) (12,076 ) (23,196 ) (183,929
) Noncontrolling interest adjustment related to impairment charges
1,016 - 1,016 -
(13,172 ) (12,076 ) (22,180 ) (183,929 ) Allocation to
participating unvested restricted stockholders 313
211 428 - Available to
common stockholders ($12,859 ) ($11,865 )
($21,752 ) ($183,929 ) Diluted loss per common share related
to charges ($0.15 ) ($0.14 ) ($0.25 ) ($2.22 ) Weighted average
diluted shares outstanding 87,500 86,402 87,374 82,828 Core:
Income from continuing operations before charges $ 34,031 $ 34,051
$ 56,362 $ 62,469 Diluted earnings per common share from continuing
operations before charges (a) $ 0.38 $ 0.39 $ 0.63 $ 0.73
Weighted average diluted shares
outstanding used to compute earnings per common share from
continuing operations before charges
87,500 86,402 87,374 84,560 Reconciliation of effective
income tax rate before charges: Effective income tax rate before
charges 30.6 % 36.0 % 31.3 % 36.7 % Impact of charges on effective
income tax rate 3.6 % 6.0 % 1.7 % -33.5
% Reported effective income tax rate 34.2 % 42.0 %
33.0 % 3.2 %
____________
(a) For purposes of computing diluted earnings per common share
before charges, income from continuing operations before charges
was reduced by $0.8 million and $0.6 million for the three months
ended June 30, 2016 and 2015, respectively, and by $1.1 million for
both the six months ended June 30, 2016 and 2015, for the
allocation of income to participating unvested restricted
stockholders.
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands)
A reconciliation of
combined Kindred and Gentiva home health revenues (excluding
community care) for each historical period follows:
Second quarter 2015 Quarters 2016 Quarters
% change v. First Second Third
Fourth First Second prior year Kindred
$ 254,965 $ 360,173 $ 356,716 $ 358,075 $ 363,730 $ 370,327 Gentiva
87,520 - - -
- - $ 342,485 $ 360,173 $
356,716 $ 358,075 $ 363,730 $ 370,327 2.8
A reconciliation of reported revenues
to same-hospital revenues for the Hospital Division for each
historical period follows:
Second quarter 2015
Quarters 2016 Quarters % change v. First
Second Third Fourth First Second
prior year Reported revenues $ 640,483 $ 627,206 $ 579,497 $
593,593 $ 643,299 $ 633,695 1.0 Hospitals acquired and sold during
2016 (a) - (16,608 ) (14,679 ) (14,695 ) - (14,346 ) Hospitals
closed during 2015 (b) (5,508 ) (5,188 )
(2,160 ) 498 114 78
Same-hospital revenues $ 634,975 $ 605,410 $ 562,658
$ 579,396 $ 643,413 $ 619,427 2.3
____________
(a)
Five hospitals acquired and three
hospitals sold during the second quarter of 2016.
(b)
One hospital closed during the second
quarter of 2015 and one hospital closed during the third quarter of
2015.
KINDRED HEALTHCARE, INC. Reconciliation of
GAAP Results to Non-GAAP Measurements (Continued)
(Unaudited) (In thousands, except per share amounts)
Three months ended June 30, 2016 Charges
Facility/ Gentiva Retirement branch
Business transaction Before As
and closings/ interruption Gain on
Litigation Impairment Research and Debt
and Other charges reported
severance consolidations settlements
facility swap contingency charges
development amendment integration
transaction Total ("core") Income from
continuing operations: Segment EBITDAR: Hospital division $
126,589 $ 446 $ - $ - $ (1,103 ) $ - $ - $ - $ - $ - $ - $ (657 ) $
125,932 Kindred at Home: Home health 75,790 - 240 (171 ) - -
- - - - - 69 75,859 Hospice 31,225 -
104 - - - -
- - - - 104 31,329
107,015 - 344 (171 )
- - - - -
- - 173 107,188
Kindred Rehabilitation Services: Kindred Hospital Rehabilitation
Services 50,469 - - - - - - - - - - - 50,469 RehabCare
13,269 - - - -
- - - - - -
- 13,269 63,738 -
- - - - -
- - - - -
63,738 Nursing center division 29,652 1,570 2,440 - -
- - - - - - 4,010 33,662 Support center (66,804 ) - - - - -
- 3,076 1,103 - - 4,179 (62,625 ) Litigation contingency expense
(930 ) - - - - 930 - - - - - 930 - Impairment charges (6,131 ) - -
- - - 6,131 - - - - 6,131 - Transaction costs (2,495 )
- - - - -
- - - 1,674 821
2,495 - EBITDAR 250,634 2,016 2,784 (171 )
(1,103 ) 930 6,131 3,076 1,103 1,674 821 17,261 267,895 Rent
(100,555 ) - 462 - - - - - - - - 462 (100,093 ) Depreciation and
amortization (40,257 ) - - - - - - - - - - - (40,257 ) Interest,
net (57,559 ) - - - -
- - - - -
- - (57,559 )
Income from continuing operations before
income taxes
52,263 2,016 3,246 (171 ) (1,103 ) 930 6,131 3,076 1,103 1,674 821
17,723 69,986 Provision for income taxes 17,882
1,448 2,331 (123 ) (8,010 )
(1,307 ) 4,403 2,209 792 1,202
590 3,535 21,417 34,381 568 915
(48 ) 6,907 2,237 1,728 867 311 472 231 14,188 48,569
Noncontrolling interests (13,522 ) - -
- - - (1,016 ) -
- - - (1,016 ) (14,538 ) Income
attributable to Kindred $ 20,859 $ 568 $ 915 $ (48 ) $ 6,907
$ 2,237 $ 712 $ 867 $ 311 $ 472 $ 231 $ 13,172
$ 34,031 Diluted earnings per common share $
0.23 $ 0.38
Diluted shares used in computing earnings
per common share
87,500 87,500
Three months ended June 30, 2015
Charges Gentiva Facility/ transaction
Before As branch Litigation and
Other charges reported closings
contingency integration transaction
Total ("core") Income from continuing
operations: Segment EBITDAR: Hospital division $ 130,967 $ 565
$ - $ - $ - $ 565 $ 131,532 Kindred at Home: Home health
72,329 588 - - - 588 72,917 Hospice 26,238
1,649 - - - 1,649
27,887 98,567 2,237 -
- - 2,237 100,804
Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services 44,531 - - - - - 44,531 RehabCare
14,681 - - - -
- 14,681 59,212 -
- - - -
59,212 Nursing center division 39,877 584 - - - 584
40,461 Support center (70,209 ) - - - - - (70,209 )
Litigation contingency expense (3,925 ) - 3,925 - - 3,925 -
Transaction costs (5,216 ) - - 4,342
874 5,216 -
EBITDAR 249,273 3,386 3,925 4,342 874 12,527 261,800 Rent (96,402 )
671 - 203 - 874 (95,528 ) Depreciation and amortization (38,625 ) -
- - - - (38,625 ) Interest, net (56,140 ) - -
- - - (56,140 )
Income from continuing operations before
income taxes
58,106 4,057 3,925 4,545 874 13,401 71,507 Provision for income
taxes 24,396 430 416 386
93 1,325 25,721 33,710 $
3,627 $ 3,509 $ 4,159 $ 781 $ 12,076 45,786
Noncontrolling interests (11,735 ) (11,735 ) Income
attributable to Kindred $ 21,975 $ 34,051
Diluted earnings per common share $ 0.25 $ 0.39
Diluted shares used in computing earnings
per common share
86,402 86,402
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands, except per share
amounts)
Six months ended June 30, 2016 Charges
Facility/ Gentiva Retirement branch
Business transaction Before As
and closings/ interruption Gain on
Litigation Impairment Research and Debt
and Other charges reported
severance consolidations settlements
facility swap contingency charges
development amendment integration
transaction Total ("core") Income from
continuing operations: Segment EBITDAR: Hospital division $
261,160 $ 1,370 $ - $ - $ (1,103 ) $ - $ - $ - $ - $ - $ - $ 267 $
261,427 Kindred at Home: Home health 142,731 - 240 (1,309 )
- - - - - - - (1,069 ) 141,662 Hospice 55,750
- 445 - - - -
- - - - 445
56,195 198,481 - 685
(1,309 ) - - - -
- - - (624 ) 197,857
Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services 98,339 - - - - - - - - - - - 98,339
RehabCare 25,256 - - -
- - - - - -
- - 25,256 123,595
- - - - -
- - - - - -
123,595 Nursing center division 59,752
1,570 2,440 - - - - - - - - 4,010 63,762 Support center
(137,612 ) 658 - - - - - 3,939 1,103 - - 5,700 (131,912 )
Litigation contingency expense (2,840 ) - - - - 2,840 - - - - -
2,840 - Impairment charges (13,919 ) - - - - - 13,919 - - - -
13,919 - Transaction costs (4,616 ) - -
- - - - - -
3,277 1,339 4,616 -
EBITDAR 484,001 3,598 3,125 (1,309 ) (1,103 ) 2,840 13,919
3,939 1,103 3,277 1,339 30,728 514,729 Rent (198,323 ) - 713 - - -
- - - - - 713 (197,610 ) Depreciation and amortization (80,938 ) -
- - - - - - - - - - (80,938 ) Interest, net (114,804 )
- - - - - -
- - - - -
(114,804 )
Income from continuing operations before
income taxes
89,936 3,598 3,838 (1,309 ) (1,103 ) 2,840 13,919 3,939 1,103 3,277
1,339 31,441 121,377 Provision for income taxes 29,718
1,591 1,698 (579 )
(4,934 ) 40 6,157
1,742 488 1,450
592 8,245 37,963 60,218
2,007 2,140 (730 ) 3,831 2,800 7,762 2,197 615 1,827 747 23,196
83,414 Noncontrolling interests (26,036 ) - -
- - - (1,016 ) -
- - - (1,016 ) (27,052 )
Income attributable to Kindred $ 34,182 $ 2,007 $ 2,140 $
(730 ) $ 3,831 $ 2,800 $ 6,746 $ 2,197 $ 615 $ 1,827
$ 747 $ 22,180 $ 56,362 Diluted
earnings per common share $ 0.38 $ 0.63
Diluted shares used in computing earnings
per common share
87,374 87,374
Six months ended June 30, 2015
Charges Gentiva Gentiva Retirement
Facility/ pre-closing transaction
Before As and branch Litigation
Impairment financing and Other
charges reported severance closings
contingency charges costs integration
transaction Total ("core") Income (loss)
from continuing operations: Segment EBITDAR: Hospital division
$ 265,078 $ - $ 1,240 $ - $ - $ - $ - $ - $ 1,240 $ 266,318
Kindred at Home: Home health 118,025 - 1,690 - - - - - 1,690
119,715 Hospice 42,717 - 2,166 -
- - - -
2,166 44,883 160,742 -
3,856 - - - -
- 3,856 164,598 Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
89,095 - - - - - - - - 89,095 RehabCare 30,389
785 - - - - -
- 785 31,174 119,484
785 - - - -
- - 785 120,269
Nursing center division 76,840 - 584 - - - - - 584 77,424
Support center (136,774 ) 4,176 - - - - - - 4,176 (132,598 )
Litigation contingency expense (98,925 ) - - 98,925 - - - - 98,925
- Impairment charges (6,726 ) - - - 6,726 - - - 6,726 - Transaction
costs (99,918 ) - - - -
6,005 90,940 2,973 99,918
- EBITDAR 279,801 4,961 5,680 98,925 6,726 6,005
90,940 2,973 216,210 496,011 Rent (188,542 ) - 1,023 - - - 792 -
1,815 (186,727 ) Depreciation and amortization (77,560 ) - - - - -
- - - (77,560 ) Interest, net (117,917 ) - -
- - 17,431 -
- 17,431 (100,486 )
Income (loss) from continuing operations
before income taxes
(104,218 ) 4,961 6,703 98,925 6,726 23,436 91,732 2,973 235,456
131,238 Provision (benefit) for income taxes (3,340 )
1,977 2,672 1,564 2,681
9,341 32,107 1,185 51,527 48,187
(100,878 ) $ 2,984 $ 4,031 $ 97,361 $ 4,045 $
14,095 $ 59,625 $ 1,788 $ 183,929 83,051 Noncontrolling
interests (20,582 ) (20,582 ) Income (loss)
attributable to Kindred $ (121,460 ) $ 62,469 Diluted
earnings (loss) per common share $ (1.47 ) $ 0.73
Diluted shares used in computing earnings
(loss) per common share
82,828 84,560
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands, except per share
amounts)
Three
months ended March 31, 2016 Charges Gentiva
Retirement Facility/ Business
transaction Before As and branch
interruption Litigation Impairment Research
and and Other charges reported
severance closings settlements
contingency charges development
integration transaction Total ("core")
Income from continuing operations: Segment EBITDAR: Hospital
division $ 134,571 $ 924 $ - $ - $ - $ - $ - $ - $ - $ 924 $
135,495 Kindred at Home: Home health 66,941 - - (1,138 ) - -
- - - (1,138 ) 65,803 Hospice 24,525 -
341 - - - - - -
341 24,866 91,466
- 341 (1,138 ) - - - -
- (797 ) 90,669 Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
47,870 - - - - - - - - - 47,870 RehabCare 11,987
- - - - - -
- - - 11,987 59,857
- - - - - -
- - - 59,857
Nursing center division 30,100 - - - - - - - - - 30,100
Support center (70,808 ) 658 - - - - 863 - - 1,521 (69,287 )
Litigation contingency expense (1,910 ) - - - 1,910 - - - - 1,910 -
Impairment charges (7,788 ) - - - - 7,788 - - - 7,788 - Transaction
costs (2,121 ) - - - -
- - 1,603 518 2,121
- EBITDAR 233,367 1,582 341 (1,138 ) 1,910 7,788 863
1,603 518 13,467 246,834 Rent (97,768 ) - 251 - - - - - - 251
(97,517 ) Depreciation and amortization (40,681 ) - - - - - - - - -
(40,681 ) Interest, net (57,245 ) - - -
- - - - - -
(57,245 )
Income from continuing operations before
income taxes
37,673 1,582 592 (1,138 ) 1,910 7,788 863 1,603 518 13,718 51,391
Provision for income taxes 11,836 543
203 (391 ) 656 2,674 296 551
178 4,710 16,546 25,837 $ 1,039
$ 389 $ (747 ) $ 1,254 $ 5,114 $ 567 $ 1,052 $ 340 $ 9,008
34,845 Noncontrolling interests (12,514 ) (12,514 )
Income attributable to Kindred $ 13,323 $ 22,331
Diluted earnings per common share $ 0.15 $ 0.25
Diluted shares used in computing earnings
per common share
87,249 87,249
Three months ended March 31, 2015
Charges Gentiva Gentiva Retirement
Facility/ pre-closing transaction
Before As and branch Litigation
Impairment financing and Other
charges reported severance closings
contingency charges costs integration
transaction Total ("core") Income (loss)
from continuing operations: Segment EBITDAR: Hospital division
$ 134,111 $ - $ 675 $ - $ - $ - $ - $ - $ 675 $ 134,786
Kindred at Home: Home health 45,696 - 1,102 - - - - - 1,102 46,798
Hospice 16,479 - 517 -
- - - - 517 16,996
62,175 - 1,619 - -
- - - 1,619 63,794
Kindred Rehabilitation Services: Kindred Hospital Rehabilitation
Services 44,564 - - - - - - - - 44,564 RehabCare 15,708
785 - - - -
- - 785 16,493 60,272
785 - - - - -
- 785 61,057 Nursing center
division 36,963 - - - - - - - - 36,963 Support center
(66,565 ) 4,176 - - - - - - 4,176 (62,389 ) Litigation contingency
expense (95,000 ) - - 95,000 - - - - 95,000 - Impairment charges
(6,726 ) - - - 6,726 - - - 6,726 - Transaction costs (94,702
) - - - - 6,005
86,598 2,099 94,702 - EBITDAR 30,528
4,961 2,294 95,000 6,726 6,005 86,598 2,099 203,683 234,211 Rent
(92,140 ) - 352 - - - 589 - 941 (91,199 ) Depreciation and
amortization (38,935 ) - - - - - - - - (38,935 ) Interest, net
(61,777 ) - - - -
17,431 - - 17,431 (44,346 )
Income (loss) from continuing operations
before income taxes
(162,324 ) 4,961 2,646 95,000 6,726 23,436 87,187 2,099 222,055
59,731 Provision (benefit) for income taxes (27,736 )
2,133 1,138 - 2,891 10,075
33,063 902 50,202 22,466
(134,588 ) $ 2,828 $ 1,508 $ 95,000 $ 3,835 $ 13,361 $
54,124 $ 1,197 $ 171,853 37,265 Noncontrolling interests
(8,847 ) (8,847 ) Income (loss) attributable to Kindred $
(143,435 ) $ 28,418 Diluted earnings (loss) per
common share $ (1.80 ) $ 0.34
Diluted shares used in computing earnings
(loss) per common share
79,575 82,422
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands, except per share
amounts)
Three months ended
September 30, 2015 Charges Gentiva
Retirement Facility/ transaction Before
As and branch Litigation and
Other charges reported severance
closings contingency integration
transaction Total ("core") Income (loss)
from continuing operations: Segment EBITDAR: Hospital division
$ 95,983 $ 666 $ 479 $ - $ - $ - $ 1,145 $ 97,128 Kindred at
Home: Home health 65,584 - 2,571 - - - 2,571 68,155 Hospice
33,707 - 318 - - -
318 34,025 99,291 -
2,889 - - - 2,889
102,180 Kindred Rehabilitation Services: Kindred
Hospital Rehabilitation Services 42,141 - - - - - - 42,141
RehabCare 14,544 - - - -
- - 14,544 56,685
- - - - - -
56,685 Nursing center division 35,923 - - - - - -
35,923 Support center (55,439 ) - - - - - - (55,439 )
Litigation contingency expense (31,462 ) - - 31,462 - - 31,462 -
Transaction costs (3,846 ) - - -
3,069 777 3,846 - EBITDAR
197,135 666 3,368 31,462 3,069 777 39,342 236,477 Rent (96,244 ) -
808 - - - 808 (95,436 ) Depreciation and amortization (39,329 ) - -
- - - - (39,329 ) Interest, net (56,008 ) - -
- - - - (56,008 )
Income from continuing operations before
income taxes
5,554 666 4,176 31,462 3,069 777 40,150 45,704 Provision for income
taxes 12,523 196 1,225 429
697 228 2,775 15,298
(6,969 ) $ 470 $ 2,951 $ 31,033 $ 2,372 $ 549 $ 37,375
30,406 Noncontrolling interests (9,900 ) (9,900 )
Income (loss) attributable to Kindred $ (16,869 ) $ 20,506
Diluted earnings (loss) per common share $ (0.20 ) $ 0.23
Diluted shares used in computing earnings
(loss) per common share
86,184 86,892
Three months ended December 31, 2015
Charges RehabCare Gentiva Retirement
Facility/ customer transaction Before
As and branch contract
Litigation Impairment and Other
charges reported severance closings
litigation contingency charges
integration transaction Total ("core")
Income from continuing operations: Segment EBITDAR: Hospital
division $ 116,454 $ 1,221 $ - $ - $ - $ - $ - $ - $ 1,221 $
117,675 Kindred at Home: Home health 67,032 - 1,794 - - - -
- 1,794 68,826 Hospice 28,668 - 1,544
- - - - -
1,544 30,212 95,700 -
3,338 - - - - -
3,338 99,038 Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
44,891 207 - - - - - - 207 45,098 RehabCare (1,118 )
112 - 12,864 - - -
- 12,976 11,858 43,773
319 - 12,864 - -
- - 13,183 56,956
Nursing center division 36,601 - - - - - - - - 36,601
Support center (63,016 ) 585 - - - - - - 585 (62,431 ) Litigation
contingency expense (8,261 ) - - - 8,261 - - 8,261 - Impairment
charges (18,031 ) - - - - 18,031 - - 18,031 - Transaction costs
(5,367 ) - - - - -
4,189 1,178 5,367 -
EBITDAR 197,853 2,125 3,338 12,864 8,261 18,031 4,189 1,178
49,986 247,839 Rent (97,823 ) - 889 - - - - - 889 (96,934 )
Depreciation and amortization (40,362 ) - - - - - - - - (40,362 )
Interest, net (55,664 ) - - - -
- - - -
(55,664 )
Income from continuing operations before
income taxes
4,004 2,125 4,227 12,864 8,261 18,031 4,189 1,178 50,875 54,879
Provision (benefit) for income taxes (51,980 ) 836
1,663 5,062 50,329 6,205
1,487 156 65,738 13,758
55,984 $ 1,289 $ 2,564 $ 7,802 $ (42,068 ) $ 11,826 $ 2,702 $ 1,022
$ (14,863 ) 41,121 Noncontrolling interests (12,082 )
(12,082 ) Income attributable to Kindred $ 43,902 $
29,039 Diluted earnings per common share $ 0.50 $
0.33
Diluted shares used in computing earnings
per common share
87,232 87,232
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands)
Three months
ended Six months ended June 30, June 30,
2016 2015 2016 2015
Reconciliation of net cash flows provided by operating activities
to free cash flows: Net cash flows provided by (used in) operating
activities
$ 135,028 $ 100,379
$ 1,966
($39,223 )
Adjustments to remove certain payments
(including payments made for discontinued operations) included in
net cash flows provided by (used in) operating activities:
Transaction, severance, retirement and retention
6,712
14,509
12,091 96,849 Business interruption settlements
(171 ) -
(1,309 ) - Ventas, Inc. lease
termination fee
3,500 -
3,500 40,000 Capitalized
lender fees related to debt refinancing
7,333 -
7,333
28,012 Other debt refinancing costs (expensed)
626 -
626 27,001 Other lease termination fees
- -
-
353 Litigation
2,030 16,575
130,449 16,575
20,030 31,084
152,690
208,790
Net cash flows provided by operating
activities excluding certain items before income tax benefit of
certain payments
155,058 131,463
154,656 169,567 Benefit of reduced
income tax payments resulting from certain payments
(28,626 ) (33,754 )
(28,626
) (33,754 )
Net cash flows provided by operating
activities excluding certain items (core operating cash flows)
126,432 97,709
126,030 135,813 Less routine
capital expenditures
(28,724 ) (24,500 )
(46,830 ) (45,269 ) Less distributions to
noncontrolling interests
(14,231 )
(10,119 )
(30,546 ) (21,138 ) Free cash
flows excluding certain items (core free cash flows)
$
83,477 $ 63,090
$ 48,654
$ 69,406
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160804006327/en/
Kindred Healthcare, Inc.Todd Flowers, 502-596-6569Investor
Relations
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Apr 2023 to Apr 2024